{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:25:16Z","timestamp":1777415116641,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":27,"publisher":"Springer US","isbn-type":[{"value":"9781071637210","type":"print"},{"value":"9781071637227","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3722-7_16","type":"book-chapter","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:02:12Z","timestamp":1715947332000},"page":"239-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Methods of Cryptococcal Polysaccharide Analysis Using ELISA"],"prefix":"10.1007","author":[{"given":"Maggie P.","family":"Wear","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth D.","family":"Greengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia Liporagi","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0923-2494(90)90099-K","volume":"141","author":"A van de Moer","year":"1990","unstructured":"van de Moer A, Salhi SL, Cherniak R et al (1990) An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan. Res Immunol 141:33\u201342","journal-title":"Res Immunol"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1128\/EC.2.4.655-663.2003","volume":"2","author":"I Bose","year":"2003","unstructured":"Bose I, Reese AJ, Ory JJ et al (2003) A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot Cell 2:655\u2013663","journal-title":"Eukaryot Cell"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.4161\/viru.1.6.13451","volume":"1","author":"MD Jesus","year":"2010","unstructured":"Jesus MD, Nicola AM, Chow S-K et al (2010) Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans. Virulence 1:500\u2013508","journal-title":"Virulence"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1128\/iai.55.3.742-748.1987","volume":"55","author":"F Dromer","year":"1987","unstructured":"Dromer F, Salamero J, Contrepois A et al (1987) Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide. Infect Immun 55:742\u2013748","journal-title":"Infect Immun"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF00518804","volume":"77","author":"RA Fromtling","year":"1982","unstructured":"Fromtling RA, Shadomy HJ (1982) Immunity in cryptococcosis: an overview. Mycopathologia 77:183\u2013190","journal-title":"Mycopathologia"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1128\/iai.55.3.749-752.1987","volume":"55","author":"F Dromer","year":"1987","unstructured":"Dromer F, Charreire J, Contrepois A et al (1987) Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect Immun 55:749\u2013752","journal-title":"Infect Immun"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/infdis\/165.6.1086","volume":"165","author":"A Casadevall","year":"1992","unstructured":"Casadevall A, Mukherjee J, Devi SJ et al (1992) Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis 165:1086\u20131093","journal-title":"J Infect Dis"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1128\/CDLI.5.2.146-159.1998","volume":"5","author":"R Cherniak","year":"1998","unstructured":"Cherniak R, Valafar H, Morris LC et al (1998) Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin Diagn Lab Immunol 5:146\u2013159","journal-title":"Clin Diagn Lab Immunol"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"9209","DOI":"10.1039\/D0SC01249A","volume":"11","author":"L Guazzelli","year":"2020","unstructured":"Guazzelli L, Ulc R, Bowen A et al (2020) A synthetic glycan array containing Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide fragments allows the mapping of protective epitopes. Chem Sci 11:9209\u20139217","journal-title":"Chem Sci"},{"key":"16_CR10","doi-asserted-by":"crossref","unstructured":"Crawford CJ, Guazzelli L, McConnell SA et al (2023) Synthetic glucuronoxylomannans enable molecular insights into antibody structure-function and fungal capsule architecture. ChemRxiv. Cambridge Open Engage, Cambridge","DOI":"10.26434\/chemrxiv-2023-nm09n"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1128\/iai.57.12.3882-3887.1989","volume":"57","author":"F Todaro-Luck","year":"1989","unstructured":"Todaro-Luck F, Reiss E, Cherniak R et al (1989) Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies. Infect Immun 57:3882\u20133887","journal-title":"Infect Immun"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1084\/jem.185.4.685","volume":"185","author":"G Nussbaum","year":"1997","unstructured":"Nussbaum G, Cleare W, Casadevall A et al (1997) Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J Exp Med 185:685\u2013694","journal-title":"J Exp Med"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1128\/IAI.70.5.2598-2604.2002","volume":"70","author":"S Shapiro","year":"2002","unstructured":"Shapiro S, Beenhouwer DO, Feldmesser M et al (2002) Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3. Infect Immun 70:2598\u20132604","journal-title":"Infect Immun"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/1-4020-5492-0_17","volume-title":"Immunology of fungal infections","author":"P Ellerbroek","year":"2007","unstructured":"Ellerbroek P, Vecchiarelli A, Hoepelman A et al (2007) Immunology of infections with Cryptococcus neoformans. In: Brown GD, Netea MG (eds) Immunology of fungal infections. Springer Netherlands, Dordrecht, pp 383\u2013407"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1074\/jbc.M116.767582","volume":"292","author":"A Bowen","year":"2017","unstructured":"Bowen A, Wear MP, Cordero RJB et al (2017) A monoclonal antibody to Cryptococcus neoformans glucuronoxylomannan manifests hydrolytic activity for both peptides and polysaccharides. J Biol Chem 292:417\u2013434","journal-title":"J Biol Chem"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"e00202","DOI":"10.1128\/IAI.00202-17","volume":"85","author":"A Bowen","year":"2017","unstructured":"Bowen A, Wear M, Casadevall A (2017) Antibody-mediated catalysis in infection and immunity. Infect Immun 85:e00202\u2013e00217","journal-title":"Infect Immun"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"12090","DOI":"10.1074\/jbc.M114.618975","volume":"290","author":"A Janda","year":"2015","unstructured":"Janda A, Eryilmaz E, Nakouzi A et al (2015) Variable region identical IgA and IgE to Cryptococcus neoformans capsular polysaccharide manifest specificity differences. J Biol Chem 290:12090\u201312100","journal-title":"J Biol Chem"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4049\/jimmunol.1202324","volume":"190","author":"RJB Cordero","year":"2013","unstructured":"Cordero RJB, Pontes B, Frases S et al (2013) Antibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties. J Immunol 190:317\u2013323","journal-title":"J Immunol"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1172\/JCI38322","volume":"120","author":"EE McClelland","year":"2010","unstructured":"McClelland EE, Nicola AM, Prados-Rosales R et al (2010) Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. J Clin Invest 120:1355\u20131361","journal-title":"J Clin Invest"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1128\/AAC.00473-11","volume":"56","author":"A Jiang","year":"2012","unstructured":"Jiang A, Bryan RA, Morgenstern A et al (2012) Treatment of early and established Cryptococcus neoformans infection with radiolabeled antibodies in immunocompetent mice. Antimicrob Agents Chemother 56:552\u2013554","journal-title":"Antimicrob Agents Chemother"},{"key":"16_CR21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2016198118","volume":"118","author":"CJ Crawford","year":"2021","unstructured":"Crawford CJ, Wear MP, Smith DFQ et al (2021) A glycan FRET assay for detection and characterization of catalytic antibodies to the Cryptococcus neoformans capsule. Proc Natl Acad Sci U S A 118:e2016198118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR22","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1084\/jem.177.4.1105","volume":"177","author":"J Mukherjee","year":"1993","unstructured":"Mukherjee J, Casadevall A, Scharff MD (1993) Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J Exp Med 177:1105\u20131116","journal-title":"J Exp Med"},{"key":"16_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2022.119547","volume":"291","author":"MP Wear","year":"2022","unstructured":"Wear MP, Hargett AA, Kelly JE et al (2022) Lyophilization induces alterations in cryptococcal exopolysaccharide resulting in reduced antibody binding. Carbohydr Polym 291:119547","journal-title":"Carbohydr Polym"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1128\/EC.00378-07","volume":"7","author":"S Frases","year":"2008","unstructured":"Frases S, Nimrichter L, Viana NB et al (2008) Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryot Cell 7:319\u2013327","journal-title":"Eukaryot Cell"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1128\/EC.00318-06","volume":"6","author":"ML Rodrigues","year":"2007","unstructured":"Rodrigues ML, Nimrichter L, Oliveira DL et al (2007) Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell 6:48\u201359","journal-title":"Eukaryot Cell"},{"key":"16_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101769","volume":"298","author":"MP Wear","year":"2021","unstructured":"Wear MP, Jacobs E, Wang S et al (2021) Cryptococcus neoformans capsule regrowth experiments reveal dynamics of enlargement and architecture. J Biol Chem 298:101769","journal-title":"J Biol Chem"},{"key":"16_CR27","volume-title":"Antibodies: a laboratory manual","author":"E Harlow","year":"1988","unstructured":"Harlow E, Lane D (1988) Antibodies: a laboratory manual. CSHL Press, Cold Spring Harbor"}],"container-title":["Methods in Molecular Biology","Cryptococcus neoformans"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3722-7_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:03:00Z","timestamp":1715947380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3722-7_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071637210","9781071637227"],"references-count":27,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3722-7_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"18 May 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}